Physician profile
Brian Eric Huff
NPI 1154783835
$28,373.50
in general payments reported to CMS, 2019-2025
16 companies · $2,906 in 2025
The $2,906 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,256 · 2020: $1,943 · 2021: $3,645 · 2022: $11K · 2023: $2,975 · 2024: $5,129 · 2025: $2,906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,880 · Food and Beverage: $4,131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,879.88 |
| Food and Beverage | $4,130.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fortis Surgical, LLC | $9,718.42 | 2021-2025 | |
| Arthrex, INC. | $5,025.48 | 2022-2025 | |
| Stryker Corporation | $4,943.25 | 2022-2025 | Mako, Triathlon, T2 Alpha |
| Rock Medical Orthopedics, INC. | $4,406.71 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $2,571.69 | 2022-2025 | Persona, Mymobility Platform, Tapestry |
| Smoky Mountain Surgical LLC | $1,006.21 | 2025 | |
| Omnilife Science, INC | $286.15 | 2025 | Apollo |
| Bioventus LLC | $149.92 | 2024-2025 | Durolane |
| Aroa Biosurgery Incorporated | $72.05 | 2025 | |
| Encore Medical, LP | $57.14 | 2023 | Djo Surgical |
| Globus Medical, INC. | $34.78 | 2024 | Onvoy, Legacy Stelkast Knee |
| Innovation Technologies INC | $24.72 | 2025 | Irrisept |
| Smith+Nephew, INC. | $23.89 | 2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Alcon Vision LLC | $19.50 | 2025 | Rocklatan |
| Music City Medical Technologies, LLC | $16.84 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $16.75 | 2023 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Huff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.